Abstract

Human papillomavirus (HPV) is the most common sexually transmitted agent worldwide. Early prevention with HPV vaccination is a safe and effective method against this disease. HPV vaccines provided more protection against several oncogenic HPV strains. Three prophylactic HPV vaccines have been approved to target high-risk HPV types and protect against HPV-related disorders. These existing vaccines are based on the recombinant DNA technology and purified L1 protein that is assembled to form HPV empty shells. The prophylactic vaccines are highly immunogenic and can induce production of specific neutralizing antibodies. However, therapeutic vaccines are different from these prophylactic vaccines. They induced cell-mediated immunity against transformed cells, instead of neutralizing antibodies. The second generation of prophylactic HPV vaccines, made from alternative viral components using cost-effective production strategies, is undergoing clinical evaluation. The purpose of this review is to provide a complete and up-to-date review of the types of HPV vaccines and the efficiency of each of them for readers.

Highlights

  • Vaccination is a low-cost and effective method to reduce the risk of infectious diseases

  • Several studies revealed that CD8+ cytotoxic T cells and CD4+ T helper 1 (TH1) cells with recognition of E2 and E6 Human papillomavirus (HPV) proteins play an important role in the clearance of low-grade HPV infection

  • Two doses of the HPV vaccine are more protective than one, but different studies have not detected statistically significant differences between two and three doses [59, 65, 73]. These findings demonstrated that HPV vaccines could induce a higher antibody response in younger girls than older girls

Read more

Summary

INTRODUCTION

Vaccination is a low-cost and effective method to reduce the risk of infectious diseases. Implementing a universal vaccination program significantly controlled and eradicated many infectious diseases and profoundly affected human health. There are effective human vaccines against different pathogens such as viruses, which induce various disorders and kill tens of millions of people each year. The human papillomavirus (HPV) is a virus that affects the different parts of the body. The HPV virus can stay in the skin and develop a genital wart. Genital warts are small bumps or growths that appear on the genitals and increase the risk of developing cervical cancer. There are many types of HPV vaccines. All HPV vaccines can protect against high-risk HPV types, including HPV16 and HPV18 that cause most HPV cancers [2–4]. This review is a comprehensive study on the available HPV vaccines and their efficiency

Update on HPV Vaccines
EPIDEMIOLOGY AND PREVALENCE OF HPV
PATHOGENESIS OF HPV INFECTION
IMMUNE RESPONSE TO HPV
IMMUNE EVASION STRATEGIES OF HPV
HPV AND ETIOLOGY OF HUMAN CANCERS
PROPHYLACTIC VACCINES
Efficacy and Immunogenicity of Prophylactic Vaccines
Expression system
CHALLENGE AND BARRIERS OF HPV VACCINES
Findings
CONCLUSIONS
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.